Correction to: Leukemia
10.1038/s41375-019-0684-5
This article was originally published under NPG’s License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
. 2020 Jan 31;34(7):1975. doi: 10.1038/s41375-020-0721-4
Correction: CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy
Ross Kinstrie
1,#, Gillian A Horne
1,#, Heather Morrison
1, David Irvine
1, Chinmay Munje
1, Eduardo Gómez Castañeda
1, Hothri A Moka
1, Karen Dunn
1, Jennifer E Cassels
1, Narissa Parry
1, Cassie J Clarke
1, Mary T Scott
1, Richard E Clark
2, Tessa L Holyoake
1, Helen Wheadon
1, Mhairi Copland
1,✉
Ross Kinstrie
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Ross Kinstrie
Gillian A Horne
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Gillian A Horne
Heather Morrison
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Heather Morrison
David Irvine
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by David Irvine
Chinmay Munje
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Chinmay Munje
Eduardo Gómez Castañeda
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Eduardo Gómez Castañeda
Hothri A Moka
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Hothri A Moka
Karen Dunn
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Karen Dunn
Jennifer E Cassels
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Jennifer E Cassels
Narissa Parry
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Narissa Parry
Cassie J Clarke
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Cassie J Clarke
Mary T Scott
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Mary T Scott
Richard E Clark
2Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Find articles by Richard E Clark
Tessa L Holyoake
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Tessa L Holyoake
Helen Wheadon
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Helen Wheadon
Mhairi Copland
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
Find articles by Mhairi Copland
1Paul O’Gorman Leukaemia Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK
2Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
✉
Corresponding author.
#
Contributed equally.
Issue date 2020.
Subject terms: Cancer stem cells, Chronic myeloid leukaemia
© The Author(s) 2020
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
PMCID: PMC8076018 PMID: 32005922
This corrects the article "CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy" on page 1613.